|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Bluebird Bio, Inc. (BLUE) |
|
|
$0.97 0.00 (-0.29%) as of 4:30 Fri 5/24
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
139,126,000 |
| Market
Cap: |
134.45(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.8871 - $4.83 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
17,438 |
35,533 |
57,514 |
116,582 |
| Total Sell Value |
$26,639 |
$61,294 |
$139,194 |
$443,003 |
| Total People Sold |
3 |
5 |
5 |
9 |
| Total Sell Transactions |
3 |
9 |
12 |
23 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cole Jason |
Chief Legal Officer |
• – – |
2017-01-05 |
4 |
S |
$67.10 |
$36,838 |
D/D |
(549) |
9,389 |
|
- |
|
| Sullivan Eric |
Principal Accounting Officer |
• – – |
2017-01-05 |
4 |
S |
$67.10 |
$15,366 |
D/D |
(229) |
5,412 |
|
- |
|
| Gregory Philip D |
Chief Scientific Officer |
• – – |
2017-01-05 |
4 |
S |
$67.10 |
$53,009 |
D/D |
(790) |
29,279 |
|
- |
|
| Leschly Nick |
President and CEO |
• • – |
2017-01-05 |
4 |
S |
$67.10 |
$135,810 |
D/D |
(2,024) |
346,346 |
|
- |
|
| Davidson David |
Chief Medical Officer |
• – – |
2017-01-05 |
4 |
S |
$67.10 |
$61,933 |
D/D |
(923) |
8,677 |
|
- |
|
| Walsh Jeffrey T. |
Chief Financialand Strategy Of |
• – – |
2017-01-05 |
4 |
S |
$67.10 |
$86,894 |
D/D |
(1,295) |
12,705 |
|
- |
|
| Leschly Nick |
President and CEO |
• • – |
2016-12-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,500 |
348,370 |
|
- |
|
| Maraganore John |
Director |
– • – |
2016-12-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,450 |
4,843 |
|
- |
|
| High Susanna Gatti |
Chief Operating Officer |
• – – |
2016-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
|
- |
|
| Sullivan Eric |
Principal Accounting Officer |
• – – |
2016-10-03 |
4 |
AS |
$67.00 |
$27,871 |
D/D |
(416) |
5,641 |
|
- |
|
| Sullivan Eric |
Principal Accounting Officer |
• – – |
2016-10-03 |
4 |
OE |
$20.70 |
$9,237 |
D/D |
416 |
6,057 |
|
- |
|
| Sullivan Eric |
Principal Accounting Officer |
• – – |
2016-09-13 |
4 |
AS |
$59.00 |
$24,544 |
D/D |
(416) |
5,641 |
|
- |
|
| Sullivan Eric |
Principal Accounting Officer |
• – – |
2016-09-13 |
4 |
OE |
$20.70 |
$9,237 |
D/D |
416 |
6,057 |
|
- |
|
| Sullivan Eric |
Principal Accounting Officer |
• – – |
2016-08-03 |
4 |
AS |
$59.00 |
$24,544 |
D/D |
(416) |
5,641 |
|
- |
|
| Sullivan Eric |
Principal Accounting Officer |
• – – |
2016-08-03 |
4 |
OE |
$20.70 |
$9,237 |
D/D |
416 |
6,057 |
|
- |
|
| Sullivan Eric |
Principal Accounting Officer |
• – – |
2016-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,935 |
5,641 |
|
- |
|
| Sullivan Eric |
Principal Accounting Officer |
• – – |
2016-07-27 |
4 |
AS |
$55.01 |
$160,178 |
D/D |
(2,912) |
2,706 |
|
- |
|
| Sullivan Eric |
Principal Accounting Officer |
• – – |
2016-07-27 |
4 |
OE |
$20.70 |
$64,659 |
D/D |
2,912 |
5,618 |
|
- |
|
| Sullivan Eric |
Principal Accounting Officer |
• – – |
2016-07-20 |
4 |
AS |
$44.85 |
$87,510 |
D/D |
(1,950) |
2,706 |
|
- |
|
| Sullivan Eric |
Principal Accounting Officer |
• – – |
2016-07-19 |
4 |
AS |
$45.40 |
$38,908 |
D/D |
(857) |
4,656 |
|
- |
|
| Davidson David |
Chief Medical Officer |
• – – |
2016-07-15 |
4 |
AS |
$45.08 |
$45,078 |
D/D |
(1,000) |
9,600 |
|
- |
|
| Davidson David |
Chief Medical Officer |
• – – |
2016-07-15 |
4 |
OE |
$2.09 |
$2,090 |
D/D |
1,000 |
10,600 |
|
- |
|
| Leschly Nick |
President and CEO |
• • – |
2016-06-24 |
4 |
OE |
$2.09 |
$76,239 |
D/D |
19,826 |
355,870 |
|
- |
|
| Gregory Philip D |
Chief Scientific Officer |
• – – |
2016-06-16 |
4 |
S |
$39.52 |
$115,833 |
D/D |
(2,931) |
30,069 |
|
- |
|
| Davidson David |
Chief Medical Officer |
• – – |
2016-06-15 |
4 |
AS |
$40.11 |
$40,112 |
D/D |
(1,000) |
9,600 |
|
- |
|
939 Records found
|
|
Page 25 of 38 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
